Results 211 to 220 of about 449,443 (354)

At the crossroads of anthropology and epidemiology: current research in cultural psychiatry in the UK. [PDF]

Transcult Psychiatry, 2013
Dein S, Bhui KS.
europepmc   +1 more source

Addressing cultural and linguistic barriers in primary care psychiatry

Chidatma Arampady, Priyanka Singhal, Aravind B. A. Banavaram, Gautham Melur Sukumar, Narayana Manjunatha, Pradeep Banandur, Channaveerachari Naveen Kumar, SureshBada Math, Jagadisha Thirthalli   +8 more
openalex   +1 more source

Managing Better Mental Health Care for BME Elders [PDF]

, 2009
Buffin, Jez, Shah, Ajit Kumar, Syed, Alia   +2 more
core  

Zuranolone: A case study in (regulatory) rush to judgement?

British Journal of Clinical Pharmacology, EarlyView.
Abstract Sage, in collaboration with Biogen, submitted a new drug approval for zuranolone for postpartum depression (PPD) and major depressive disorder (MDD) in December 2022. In August 2023, the US Food and Drug Administration granted approval for PPD but denied approval for MDD.
Lisa Cosgrove, Milutin Kostic, Barbara Mintzes, Gianna D'Ambrozio, Allen Shaughnessy   +4 more
wiley   +1 more source

Understanding somatisation through Cross-Cultural Liaison psychiatry

, 2008
Sílvia Ferrari, Davide Malmusi, C. Giubbarelli, Luca Pingani, Marco Rigatelli   +4 more
openalex   +1 more source

A Hopeful Dystopian Future for Social and Cultural Psychiatry

Kamaldeep Bhui
openalex   +1 more source

Medico-Legal and Cultural Influences on Ethical Attitudes in Psychiatry: A Cross-Sectional Comparison of U.S. and French Practitioners [PDF]

Colin Charbel Cordahi, Sami Richa, Butool Durrani, Ramez Dagher, Rachel Johnson, Maissa Safieddine, Sirine Anouti, Laurent Ravez, Nancy Choucair Alam, Yasser Kazaal, Laura Warck, Wissam El‐Hage, Ziad Nahas   +12 more
openalex   +1 more source

ETHNOPSYCHIATRIC INTERPRETATIONS OF SCHIZOPHRENIC ILLNESS: THE PROBLEM OF NERVIOS WITHIN MEXICAN-AMERICAN FAMILIES [PDF]

, 1988
A. Kiev, A. Kleinman, A. Kleinman, A. Kleinman, B. J. Good, B. J. Good, B. J. Good, C. Hughes, C. Lutz, C. Lutz, C. Lutz, C. Vaughn, C. Vaughn, C. Vaughn, E. Schieffelin, F. Myers, F. Newton, G. Brown, G. W. Brown, G. White, H. Fabrega, H. Fabrega, H. Rin, I. Cuellar, I. I. Gottesman, J. H. Jenkins, J. H. Jenkins, J. Henry, J. M. Gilbert, J. M. Janzen, J. Murphy, J. Murphy, J. Townsend, J. Townsend, L. Rogler, L. Wynne, M. Bleuler, M. Karno, M. Locke, M. Rosaldo, M. Tousignant, N. Murillo, N. Sartorius, N. Scheper-Hughes, N. Scheper-Hughes, N. Waxler, O. Ramirez, R. B. Edgerton, R. B. Edgerton, R. B. Edgerton, R. C. Solomon, S. E. Keefe, S. Estroff, S. Estroff, S. Keefe, S. Low, S. Low, T. Y. Lin, V. Gecas, World Health Organization   +59 more
core   +1 more source

HLA genotype testing for carbamazepine, oxcarbazepine and eslicarbazepine: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI‐PGx)

British Journal of Clinical Pharmacology, EarlyView.
Carbamazepine is licensed in the United Kingdom for the treatment of epilepsy, bipolar disorder and trigeminal neuralgia. The related compounds oxcarbazepine and eslicarbazepine are licensed for the treatment of epilepsy. These drugs can cause immune‐mediated hypersensitivity reactions, which typically affect the skin, and can be of variable severity ...
Lucy Galloway, Cinzia Dello Russo, Nicholas Bass, Elvira Bramon, Helen Cross, Natalie Curley, Sarah Curran, Helen Davies, Jana De Villiers, William Evans, Bernhard Frank, Alice Groves, Judith Hayward, Jon Higham, Dyfrig A. Hughes, Shwe Sin Kyaw, Anthony G. Marson, Ailsa McLellan, Seth Mensah, Francis O'Neill, Jane Sargison, Sanjay M. Sisodiya, Jill Swan, Joanna M. Zakrewska, Munir Pirmohamed   +24 more
wiley   +1 more source

Beyond the bilingualism myth: toward culturally sustaining autism interventions for multilingual families. [PDF]

Front Psychiatry
Castellón FA, Gómez LR, Ramos-Gallardo T.   +2 more
europepmc   +1 more source